Showing results (11-20 of 552) with videos related to
Sort By:
Pageof 56
The Lancet. Oncology|February 2, 2013
Which drug, and when, for patients with BRAF-mutant melanoma?Sekwon Jang, Michael B AtkinsBritish Medical Journal|November 23, 1974
Communications between general practitioners and consultantsA Long, J B AtkinsClinical Pharmacology and Therapeutics|October 2, 2013
Treatment of BRAF-mutant melanoma: the role of vemurafenib and other therapiesS Jang, M B AtkinsCancer Treatment and Research|November 26, 2015
Treatment of Melanoma CNS MetastasesSekwon Jang, Michael B AtkinsCureus|March 4, 2026
Stigma and Access to Mental Healthcare Among US VeteransJustin B Atkins, Ronnie JosephJournal of the National Cancer Institute|February 4, 2016
Immunotherapy Combined or Sequenced With Targeted Therapy in the Treatment of Solid Tumors: Current PerspectivesMichael B Atkins, James LarkinExpert Review of Anticancer Therapy|April 28, 2022
Adjuvant therapy for patients with renal cell carcinoma following surgery: a focus on pembrolizumabMichael Serzan, Michael B AtkinsNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 6, 1999
Outcome and complications of temporary haemodialysis cathetersL K Kairaitis, T GottliebMycoses|February 1, 2002
Case report. Successful treatment of cutaneous Paecilomyces lilacinus infection with oral itraconazole in an immune competent hostT Gottlieb, B L AtkinsAustralian and New Zealand Journal of Medicine|June 1, 1989
Community-acquired Acinetobacter pneumoniaT Gottlieb, D J BarnesPageof 56